Frankincense Superior to Chemotherapy in Killing Late-Stage Ovarian Cancer Cells

Frankincense Superior to Chemotherapy in Killing Late-Stage Ovarian Cancer Cells
Madeleine Steinbach/Shutterstock
|Updated:
0:00
Like the Magi, carrying myrrh, frankincense, and gold, researchers from the University of Leicester have, for the first time, demonstrated the potential of treating ovarian cancer using the Christmas gift frankincense.

The origins of frankincense can be traced to the Arabian Peninsula. According to Herodotus (fifth century B.C.):

“Arabia is the only country which produces frankincense, myrrh, cassia, and cinnamon ... the trees bearing the frankincense are guarded by winged serpents of small size and various colors.” (See this GreenMedInfo summary).”

Frankincense, along with gold and myrrh, is one of the most famous Christmas presents in history and is a fragrant plant resin extracted from the Boswellia sacra tree found across Africa and Arabia. Using the compound AKBA (acetyl-11-keto-beta-boswellic acid) derived from the resin, the research has successfully shown its potential effectiveness in targeting ovarian cancer.

More specifically, they have been able to demonstrate the ability of AKBA to combat cancer cells in late-stage ovarian cancer.

Lead researcher Kamla Al-Salmani, a doctorate student from the University’s Department of Cancer Studies and Molecular Medicine explained:

Related Topics